Researchers monitor cancer drug's real-world effects in 600 patients
NCT ID NCT07035886
First seen Dec 29, 2025 · Last updated May 12, 2026 · Updated 24 times
Summary
This study observes 600 adults with colorectal cancer who are already taking the drug fruquintinib as part of their normal care in South Korea. The goal is to track any side effects and see how many patients are alive and without cancer growth after 6 months. No new treatments or procedures are given; it simply collects information from routine use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yonsei University Hospital
RECRUITINGSeoul, 03722, South Korea
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.